What is the current ALNA stock price and volume?

ALNA is trading pre-market at USD 0.075 with reported volume of 252,311,606 shares and an intraday range of USD 0.06 to USD 0.1459 on NASDAQ in the United States.

What are the main financial risks for Allena Pharmaceuticals?

Key risks include negative EPS of -0.638, negative operating cash flow per share (-1.405), limited revenue, and dependence on clinical progress and funding to sustain operations.

How does Meyka AI rate ALNA and what does it mean?

Meyka AI rates ALNA 62.74623085761357 (Grade B) with a HOLD suggestion. The grade blends benchmark, sector, financial growth, metrics, forecasts, and consensus. It is informational, not investment advice.

What price targets does the Meyka model show for ALNA?

Meyka AI's forecast model projects a base-case target of USD 0.120, a bull target of USD 0.200, and a bear target of USD 0.030 versus the current USD 0.075; these are projections, not guarantees.

US Stocks

ALNA pre-market +3.16% on 252,311,606 shares 06 Jan 2026: check catalysts

ByDanny Kontos January 6, 2026January 6, 2026

The ALNA stock opened pre-market at USD 0.075, up 3.16% on heavy volume of 252,311,606 shares on NASDAQ in the United States. That move follows an intraday range from USD 0.06 to USD 0.1459 and a previous close of USD 0.0727. Traders are watching liquidity and any clinical or corporate news that could move this micro-cap biotechnology name. We use Meyka AI-powered market analysis to link the price action to the company’s financial profile and short-term outlook.